Total Payments
$19,821
2024 Payments
$1,909
Companies
73
Transactions
1,120
Medicare Patients
2,792
Medicare Billing
$401,851
Payment Breakdown by Category
Food & Beverage$19,019 (96.0%)
Education$747.87 (3.8%)
Other$54.44 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,019 | 1,093 | 96.0% |
| Education | $747.87 | 24 | 3.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54.44 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,411 | 69 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,409 | 113 | $0 (2023) |
| Biogen, Inc. | $1,321 | 83 | $0 (2024) |
| GENZYME CORPORATION | $1,152 | 57 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $1,130 | 35 | $0 (2024) |
| ABBVIE INC. | $1,073 | 85 | $0 (2024) |
| Genentech USA, Inc. | $896.21 | 47 | $0 (2024) |
| Lundbeck LLC | $825.59 | 51 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $811.01 | 24 | $0 (2022) |
| EMD Serono, Inc. | $549.20 | 40 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,909 | 75 | Alexion Pharmaceuticals, Inc. ($322.75) |
| 2023 | $2,205 | 115 | ABBVIE INC. ($247.12) |
| 2022 | $2,690 | 138 | ABBVIE INC. ($368.59) |
| 2021 | $2,494 | 157 | Novartis Pharmaceuticals Corporation ($347.30) |
| 2020 | $1,471 | 106 | Novartis Pharmaceuticals Corporation ($208.35) |
| 2019 | $3,082 | 180 | Novartis Pharmaceuticals Corporation ($529.18) |
| 2018 | $3,408 | 161 | Lundbeck LLC ($320.30) |
| 2017 | $2,562 | 188 | GENZYME CORPORATION ($316.58) |
All Payment Transactions
1,120 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $53.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Neurology | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $6.78 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: EPILEPSY | ||||||
| 10/28/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: EPILEPSY | ||||||
| 10/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 10/01/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $5.01 | General |
| 09/25/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $0.88 | General |
| 09/23/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Neuroscience | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: Neurology | ||||||
| 08/22/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 803 | 1,008 | $398,799 | $114,385 |
| 2022 | 12 | 760 | 933 | $377,346 | $107,548 |
| 2021 | 12 | 686 | 867 | $346,641 | $105,574 |
| 2020 | 11 | 543 | 672 | $279,562 | $74,344 |
Total Patients
2,792
Total Services
3,480
Medicare Billing
$401,851
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 160 | 220 | $93,720 | $28,682 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 142 | 190 | $60,420 | $17,800 | 29.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 87 | 173 | $43,154 | $12,861 | 29.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 92 | 92 | $44,988 | $10,323 | 22.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 59 | 59 | $35,990 | $9,711 | 27.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 47 | 49 | $23,169 | $8,123 | 35.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 48 | 48 | $27,456 | $5,976 | 21.8% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2023 | 44 | 45 | $19,575 | $5,458 | 27.9% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 23 | 23 | $12,949 | $4,497 | 34.7% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 44 | 44 | $16,280 | $4,339 | 26.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 26 | $7,722 | $2,405 | 31.1% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 12 | 12 | $7,571 | $2,274 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 27 | $5,805 | $1,936 | 33.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 115 | 174 | $74,124 | $23,092 | 31.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 96 | 97 | $55,484 | $14,208 | 25.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 83 | 157 | $40,506 | $12,294 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 116 | $36,888 | $10,138 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $33,741 | $8,284 | 24.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 45 | 45 | $21,645 | $7,897 | 36.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 42 | 42 | $25,620 | $6,924 | 27.0% |
| 95924 | Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt | Office | 2022 | 52 | 53 | $23,055 | $6,276 | 27.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 70 | $20,790 | $5,521 | 26.6% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 52 | 53 | $19,610 | $5,359 | 27.3% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2022 | 21 | 21 | $11,823 | $3,945 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 16 | 16 | $9,760 | $2,142 | 22.0% |
About Eric Floranda
Eric Floranda is a Neuromuscular Medicine healthcare provider based in Midlothian, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/25/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942479803.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Eric Floranda has received a total of $19,821 in payments from pharmaceutical and medical device companies, with $1,909 received in 2024. These payments were reported across 1,120 transactions from 73 companies. The most common payment nature is "Food and Beverage" ($19,019).
As a Medicare-enrolled provider, Floranda has provided services to 2,792 Medicare beneficiaries, totaling 3,480 services with total Medicare billing of $401,851. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Neuromuscular Medicine
- Other Specialties Neurology, Neuromuscular Medicine
- Location Midlothian, VA
- Active Since 02/25/2008
- Last Updated 08/18/2016
- Taxonomy Code 2084N0008X
- Entity Type Individual
- NPI Number 1942479803
Products in Payments
- Briviact (Drug) $925.07
- AIMOVIG (Biological) $682.94
- NURTEC ODT (Drug) $679.97
- AUBAGIO (Drug) $669.53
- OCREVUS (Biological) $579.61
- ULTOMIRIS (Biological) $534.71
- TYSABRI (Biological) $520.28
- NORTHERA (Drug) $449.43
- UBRELVY (Drug) $441.89
- APTIOM (Drug) $438.01
- QULIPTA (Drug) $433.08
- BOTOX (Biological) $397.00
- LEMTRADA (Drug) $384.24
- TROKENDI XR (Drug) $350.41
- Aimovig (Biological) $335.10
- SOLIRIS (Drug) $330.91
- Rebif (Biological) $324.76
- Hizentra (Biological) $324.45
- TECFIDERA (Drug) $279.79
- GOCOVRI (Drug) $271.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.